| __timestamp | Regeneron Pharmaceuticals, Inc. | Wave Life Sciences Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 504755000 | 2999000 |
| Thursday, January 1, 2015 | 838526000 | 10393000 |
| Friday, January 1, 2016 | 1177697000 | 15994000 |
| Sunday, January 1, 2017 | 1320433000 | 26975000 |
| Monday, January 1, 2018 | 1556200000 | 39509000 |
| Tuesday, January 1, 2019 | 1834800000 | 48869000 |
| Wednesday, January 1, 2020 | 1346000000 | 42510000 |
| Friday, January 1, 2021 | 1824900000 | 46105000 |
| Saturday, January 1, 2022 | 2115900000 | 50513000 |
| Sunday, January 1, 2023 | 2631300000 | 51292000 |
| Monday, January 1, 2024 | 2954400000 |
Infusing magic into the data realm
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. Over the past decade, Regeneron Pharmaceuticals, Inc. and Wave Life Sciences Ltd. have taken different paths in optimizing these costs. From 2014 to 2023, Regeneron saw a staggering 420% increase in SG&A expenses, peaking at $2.63 billion in 2023. In contrast, Wave Life Sciences maintained a more modest growth, with expenses rising by approximately 1,610% to $51 million in the same period.
Regeneron's substantial increase reflects its aggressive expansion and investment in administrative capabilities, while Wave's steady rise suggests a more conservative approach. This divergence highlights the strategic choices companies make in balancing growth and cost management. As the biotech landscape evolves, these strategies will play a pivotal role in determining long-term success.
SG&A Efficiency Analysis: Comparing Bristol-Myers Squibb Company and Wave Life Sciences Ltd.
Selling, General, and Administrative Costs: Gilead Sciences, Inc. vs Regeneron Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Vertex Pharmaceuticals Incorporated and Regeneron Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs Takeda Pharmaceutical Company Limited
Regeneron Pharmaceuticals, Inc. or Opthea Limited: Who Manages SG&A Costs Better?
Regeneron Pharmaceuticals, Inc. vs Jazz Pharmaceuticals plc: SG&A Expense Trends
Selling, General, and Administrative Costs: Regeneron Pharmaceuticals, Inc. vs Soleno Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Regeneron Pharmaceuticals, Inc. and Veracyte, Inc.
Comparing SG&A Expenses: Summit Therapeutics Inc. vs Wave Life Sciences Ltd. Trends and Insights
Who Optimizes SG&A Costs Better? Insmed Incorporated or Wave Life Sciences Ltd.
Comparing SG&A Expenses: Cytokinetics, Incorporated vs Wave Life Sciences Ltd. Trends and Insights
Comparing SG&A Expenses: Vericel Corporation vs Wave Life Sciences Ltd. Trends and Insights